BIOCRYST PHARMACEUTICALS, INC. (BCRX) scores 57 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 16.37, representing a 75% margin of safety. Quantitative score: 58/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.